The fifth round of national procurement, the country's landing situation

The fifth batch of national procurement, the country will be launched soon

According to Cyberlan statistics, as of now, the fifth batch of national sourcing has already landed in 6 provinces, and a new round of market segmentation for more than 60 large varieties has begun

In addition, a total of 23 provinces have clarified the implementation time of the five rounds of national procurement

Cyberlan's statistics today found that six provinces including Xinjiang, Tianjin, Henan, Tibet, Hebei, and Chongqing have implemented the fifth batch of national procurement results, of which Henan, Tibet, Hebei, and Chongqing are all implemented on October 1

In addition to the above six provinces, 17 provinces including Yunnan, Guangdong, and Hainan have also clarified the implementation time of the fifth round of national procurement.

According to Cyberlan statistics, the provinces that have not yet given the implementation time of the fifth round of national procurement are Jilin, Jiangsu, Anhui, Sichuan, Qinghai, Ningxia, Inner Mongolia, and Beijing

According to previous official news from the National Medical Insurance Administration, the fifth batch of national procurement will land nationwide in October.

In addition, on September 10, Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Announcement on the List of Enterprises and Products Related to the Sixth Batch of National Organizations for Centralized Drug Purchasing (Insulin Special)", announcing the start of the sixth batch of national procurement (Insulin Special)

With the firing of the starting guns of the sixth batch of national mining companies, the nationwide landing of the fifth batch of national mining companies will also speed up

It is worth noting that with the implementation of the fifth batch of national sourcing, the price reduction and withdrawal of unselected products and products that have not passed the consistency evaluation have also begun

On September 28, Henan Province issued a notice on the evaluation results of the fifth batch of non-selected drugs that were collected by the country.

According to the relevant policies and regulations of centralized procurement, if there are more than 3 manufacturers of the same type of drugs that have passed the consistency evaluation, the products that have not passed the consistency evaluation will no longer be selected under the condition of ensuring the supply

Central setting: the continuous advancement of centralized procurement

Looking back at the centralized procurement of chemical medicines, from the perspectives of the varieties accepted by the first five batches of countries, the number of varieties accepted in each round of centralized procurement has increased, and the proportion of injections has also continued to expand

At present, the first five batches of national procurement have covered 218 varieties, and the special national procurement of insulin has also been officially launched

On September 29, the General Office of the State Council issued an important programmatic document "The 14th Five-Year Plan for National Medical Insurance" for medical insurance work in the next few years

According to the main indicators for the development of universal medical security during the "14th Five-Year Plan" period, the number of drugs purchased in a centralized manner is expected to exceed 500 by 2025

The plan calls for the deepening of the reform of the centralized procurement system for drugs and medical consumables — the normalized and institutionalized implementation of the state-organized centralized procurement of pharmaceuticals, and the continuous expansion of the state-organized centralized procurement of high-value medical consumables

Strengthen the unified guidance for centralized procurement agencies, standardize the local implementation of centralized and volume procurement, and form a work pattern in which national, provincial, and cross-regional alliance procurement cooperate with each other and advance together
.

Establish a provincial centralized procurement platform that integrates bidding, procurement, transaction, settlement, and supervision based on medical insurance payment
.
Promote centralized mass procurement to become the dominant mode of pharmaceutical procurement for public medical institutions, and encourage social medical institutions and designated retail pharmacies to participate in centralized mass procurement
.

In other words, there will be nearly 300 varieties in the follow-up, which will be successively included in the national procurement
.
With reference to the previous five rounds and six batches of rules, it is expected that the company will be eligible to be selected or will still be one of the three conditions-meeting 1.
8 times the fuse mechanism, 50% or more of the comparable price reduction unit, and less than or equal to 0.
1 yuan
.

Previously, Gong Bo, director of the Medical Price and Bidding Purchasing Department of the Shanghai Medical Insurance Bureau, told the media that there are now more than 620 clinical drugs, which can cover 80% of all purchases
.

Among more than 620 kinds of medicines, chemicals account for about 490 kinds
.
At present, the national centralized procurement products are mainly for chemical drugs.
I hope that 490 kinds of chemical drugs can be included in the centralized procurement as much as possible in the recent stage.
At present, the fifth batch has covered 218 species.
I hope that the number will increase in the next year and the next year.

.

It is not difficult to see that follow-up chemical medicine is still the main theme of national procurement
.

At this stage, the sixth batch of national procurement (insulin special projects) is in the process of reporting.
According to the notice, on September 17, all provinces officially started data reporting
.

After completing the submission by the provincial medical institutions, each province needs to complete the review of the historical purchases and purchase requirements of the second and third generation insulins before 17:00 on October 15 (Friday), and submit the electronic files and scanned copies together.
To the Joint Procurement Office
.

According to the previous rounds of national procurement, after the completion of the reporting work (October 15), this round of insulin special project will enter the stage of issuing centralized procurement documents.
The time and location of bid opening, and possible product price limit will be Clear at this stage
.

After the bid opening is over, the sudden national procurement of insulin will enter the stage of the announcement of the results of the proposed selection, the announcement of the results of the selection, and the preparation stage before the collection
.

According to the schedule of the draft for comments, the related work of centralized insulin procurement will be started in September and will be implemented in early 2022, with a two-year cycle
.
Immediately thereafter, the continued inclusion of drugs that meet the conditions into centralized procurement is expected to remain a normalized event
.